Patent · US Active

Modified CEA/B7 vector

US8562970B2 · kind B2 · utility

0Cited by
90References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 6, 2004
Grant dateOct 22, 2013
Priority date
Expiry dateAug 12, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2799/023
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.